動物用ワクチンの世界市場予測(~2022年):種類、疾患、技術別分析

MarketsandMarketsが発行した調査報告書(PH-3475)
◆英語タイトル:Veterinary/Animal Vaccines Market by Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2022
◆商品コード:PH-3475
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2017年11月2日
◆ページ数:158
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

MarketsandMarketsが発行した当調査レポートでは、動物用ワクチンの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、疾患別分析、技術別分析、地域別分析、動物用ワクチンの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・動物用ワクチンの世界市場:市場インサイト
・動物用ワクチンの世界市場:市場概観/市場動向
・動物用ワクチンの世界市場:種類別分析/市場規模
・動物用ワクチンの世界市場:疾患別分析/市場規模
・動物用ワクチンの世界市場:技術別分析/市場規模
・動物用ワクチンの世界市場:地域別分析/市場規模
・動物用ワクチンのアジア市場規模予測
・動物用ワクチンのヨーロッパ市場規模予測
・動物用ワクチンのアメリカ市場規模予測
・動物用ワクチンの世界市場動向
・動物用ワクチンの世界市場:競争状況
・動物用ワクチンの世界市場:関連企業分析
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

“Veterinary Vaccines market is projected to register a CAGR of 5.9%”The veterinary vaccines market is expected to reach USD 8.66 billion by 2022 from USD 6.50 billion in 2017, growing at a CAGR of 5.9% during the forecast period. Market growth can be attributed to factors such as growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines in the market. On the other hand, the high storage cost for vaccines is expected to restrain the market to a certain extent.
“The companion animal vaccines segment is expected to grow at the highest rate during the forecast period”
On the basis of type, the veterinary vaccines market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and other vaccines. The companion animal vaccines segment is divided into canine vaccines and feline vaccines and in terms of value, the companion animal vaccines segment is expected grow at the highest CAGR during the forecast period. Increasing awareness about companion animal vaccination, rising prevalence of zoonotic diseases in humans, and the growing number of pets and increasing pet ownership are fueling the demand for these vaccines.
“The live attenuated vaccines segment is expected to account for the largest share of the market in 2017”
By technology, the market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines. In terms of value, the live attenuated vaccines segment is expected to account for the largest share of the market in 2017. The ease of administration and long-term immunity offered by the live attenuated vaccine technologies are driving the demand for this segment in the veterinary vaccines industry.
“Asia Pacific to provide significant growth opportunities during the forecast period”
Geographically, Europe is the largest market for veterinary vaccines market, followed by North America but the APAC region is expected to witness the highest growth in the forecast period. This growth is primarily attributed to rising pet adoption, expansion of key vaccine players in the region, and the wide range of product launches and investments in veterinary vaccines manufacturing facilities in the region, especially in India, China, and Thailand.
Break-up profile of primaries:
• By Company Type- Tier 1-40%, Tier 2-35% and Tier 3-25%
• By Designation-C-level-33%, D-level-41% and Others-26%
• By Region-North America-35%, Europe-30%, Asia-21%, and RoW-14%
The key players in the veterinary vaccines market are Zoetis (US), Merck Animal Health (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac (France).
Research Coverage:
The veterinary vaccines market in this report is segmented by type, disease, technology, and region. The study tracks and analyzes competitive developments such as product launches; expansions; agreements, partnerships, and collaborations; and acquisitions. It also profiles the key players and their core competencies within the veterinary vaccines market.
Reasons to buy this report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on portfolios offered by the top players in the global veterinary vaccines market. The report analyzes the veterinary vaccines market by type, disease, technology, and region.

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the veterinary vaccines market

• Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for veterinary vaccines across regions

• Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global veterinary vaccines market

• Competitive Assessment: In-depth assessment of, strategies, products, and manufacturing capabilities of the key players in the global veterinary vaccines market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 SECONDARY DATA 18
2.1.1.1 Key data from secondary sources 18
2.1.2 PRIMARY DATA 18
2.1.2.1 Key data from primary sources 19
2.1.2.2 Breakdown of primary interviews 19
2.1.2.3 Key industry insights 20
2.2 MARKET SIZE ESTIMATION 20
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.3.1 RESEARCH ASSUMPTIONS 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 27
4.1 GLOBAL VETERINARY VACCINES MARKET OVERVIEW 27
4.2 APAC VETERINARY VACCINES MARKET, BY TECHNOLOGY AND REGION 28
4.3 POULTRY VETERINARY VACCINES MARKET, BY DISEASE 29
4.4 VETERINARY VACCINES MARKET, BY GEOGRAPHY 29
5 MARKET OVERVIEW 30
5.1 INTRODUCTION 30
5.2 MARKET DYNAMICS 30
5.2.1 DRIVERS 31
5.2.1.1 Growth in livestock population and repeated outbreaks of livestock diseases 31
5.2.1.2 Increasing adoption of companion animals 31
5.2.1.3 Rising incidence of zoonotic diseases 33
5.2.1.4 Initiatives by various government agencies, animal associations, and leading players 33
5.2.1.5 Introduction of new types of vaccines 34
5.2.2 RESTRAINTS 34
5.2.2.1 High storage costs for vaccines 34
5.2.3 OPPORTUNITIES 35
5.2.3.1 Technological advancements 35
5.2.3.2 Growing awareness of animal health in emerging economies 35
5.2.4 CHALLENGE 36
5.2.4.1 Inadequate surveillance and reporting systems 36
6 VETERINARY VACCINES MARKET, BY TYPE 37
6.1 INTRODUCTION 38
6.2 PORCINE VACCINES 39
6.3 POULTRY VACCINES 41
6.4 LIVESTOCK VACCINES 42
6.4.1 BOVINE VACCINES 44
6.4.2 SMALL RUMINANT VACCINES 45
6.5 COMPANION ANIMAL VACCINES 46
6.5.1 CANINE VACCINES 48
6.5.2 FELINE VACCINES 49
6.6 AQUACULTURE VACCINES 51
6.7 OTHER ANIMAL VACCINES 52
7 VETERINARY VACCINES MARKET, BY DISEASE 53
7.1 INTRODUCTION 54
7.2 PORCINE 54
7.3 POULTRY 58
7.4 LIVESTOCK 62
7.4.1 BOVINE 63
7.4.2 SMALL RUMINANTS 65
7.5 COMPANION ANIMALS 66
7.5.1 CANINE 66
7.5.2 FELINE 66
7.6 AQUACULTURE 67

8 VETERINARY VACCINES MARKET, BY TECHNOLOGY 68
8.1 INTRODUCTION 69
8.2 LIVE ATTENUATED VACCINES 70
8.3 INACTIVATED VACCINES 71
8.4 TOXOID VACCINES 72
8.5 RECOMBINANT VACCINES 74
8.6 OTHER VACCINES 75
9 VETERINARY VACCINES MARKET, BY REGION 77
9.1 INTRODUCTION 78
9.2 EUROPE 79
9.3 NORTH AMERICA 83
9.3.1 US 87
9.3.2 CANADA 90
9.4 ASIA PACIFIC (APAC) 93
9.4.1 CHINA 98
9.4.2 THAILAND 101
9.4.3 INDIA 103
9.4.4 REST OF APAC 106
9.5 REST OF THE WORLD 109
10 COMPETITIVE LANDSCAPE 112
10.1 MARKET RANKING ANALYSIS 112
11 COMPANY PROFILES 113
(BUSINESS OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*
11.1 ZOETIS 113
11.2 MERCK ANIMAL HEALTH 116
11.3 BOEHRINGER INGELHEIM 119
11.4 ELANCO 122
11.5 CEVA 125
11.6 VIRBAC 128
11.7 VETOQUINOL 131
11.8 PHIBRO ANIMAL HEALTH 133
11.9 HESTER 136
11.10 HIPRA 138
11.11 IDT BIOLOGIKA 140
11.12 BIOGENESIS BAGO 142
11.13 TIANJIN RINGPU 143
11.14 CHINA ANIMAL HUSBANDRY 144
11.15 JINYU BIO-TECHNOLOGY 146
*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.
12 APPENDIX 147
12.1 INSIGHTS OF INDUSTRY EXPERTS 147
12.2 DISCUSSION GUIDE 148
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 151
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 153
12.5 AVAILABLE CUSTOMIZATIONS 155
12.6 RELATED REPORTS 155
12.7 AUTHOR DETAILS 156

LIST OF TABLES

TABLE 1 GLOBAL LIVESTOCK ANIMAL POPULATION, 2000 AND 2013 31
TABLE 2 ANIMAL DISEASE OUTBREAKS REPORTED IN RECENT YEARS 31
TABLE 3 PERCENTAGE OF PET OWNERSHIP, BY COUNTRY, 2016 32
TABLE 4 SMALL COMPANION ANIMAL POPULATION, BY COUNTRY, 2014 VS. 2016 (MILLION) 32
TABLE 5 VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 39
TABLE 6 PORCINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 40
TABLE 7 NORTH AMERICA: PORCINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 40
TABLE 8 ASIA PACIFIC: PORCINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 40
TABLE 9 POULTRY VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 41
TABLE 10 NORTH AMERICA: POULTRY VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 41
TABLE 11 ASIA PACIFIC: POULTRY VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 42
TABLE 12 LIVESTOCK VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 42
TABLE 13 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 43
TABLE 14 ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 43
TABLE 15 LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 43
TABLE 16 BOVINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 17 NORTH AMERICA: BOVINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 44
TABLE 18 ASIA PACIFIC: BOVINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 45
TABLE 19 SMALL RUMINANT VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 45
TABLE 20 NORTH AMERICA: SMALL RUMINANT VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 46
TABLE 21 ASIA PACIFIC: SMALL RUMINANT VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 46
TABLE 22 COMPANION ANIMAL VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 47
TABLE 23 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 47
TABLE 24 ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 47
TABLE 25 COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 48
TABLE 26 CANINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 48
TABLE 27 NORTH AMERICA: CANINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 49
TABLE 28 ASIA PACIFIC: CANINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 49
TABLE 29 FELINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 30 NORTH AMERICA: FELINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 50
TABLE 31 ASIA PACIFIC: FELINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 50
TABLE 32 AQUACULTURE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 51
TABLE 33 NORTH AMERICA: AQUACULTURE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 51
TABLE 34 OTHER ANIMAL VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 52
TABLE 35 NORTH AMERICA: OTHER ANIMAL VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 52
TABLE 36 PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 54
TABLE 37 PORCINE CIRCOVIRUS II VACCINES MARKET, BY REGION,
2015–2022 (USD MILLION) 55
TABLE 38 NORTH AMERICA: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 55
TABLE 39 ASIA PACIFIC: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 55
TABLE 40 PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET,
BY REGION, 2015–2022 (USD MILLION) 56
TABLE 41 NORTH AMERICA: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 56
TABLE 42 ASIA PACIFIC: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 57
TABLE 43 PORCINE PARVOVIRUS VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 57
TABLE 44 NORTH AMERICA: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 57
TABLE 45 ASIA PACIFIC: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 58
TABLE 46 POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 59
TABLE 47 INFECTIOUS BRONCHITIS VACCINES MARKET, BY REGION,
2015–2022 (USD MILLION) 59
TABLE 48 NORTH AMERICA: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 59
TABLE 49 ASIA PACIFIC: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 60
TABLE 50 AVIAN INFLUENZA VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 60
TABLE 51 NORTH AMERICA: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 61
TABLE 52 ASIA PACIFIC: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 61
TABLE 53 NEWCASTLE DISEASE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 61
TABLE 54 NORTH AMERICA: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 62
TABLE 55 ASIA PACIFIC: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 62
TABLE 56 BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 63
TABLE 57 FOOT-AND-MOUTH DISEASE VACCINES MARKET, BY REGION,
2015–2022 (USD MILLION) 63
TABLE 58 BOVINE VIRAL DIARRHEA VACCINES MARKET, BY REGION,
2015–2022 (USD MILLION) 64
TABLE 59 BOVINE CLOSTRIDIAL DISEASE VACCINES MARKET, BY REGION,
2015–2022 (USD MILLION) 64
TABLE 60 BRUCELLOSIS VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 65
TABLE 61 SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 65
TABLE 62 CANINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 66
TABLE 63 FELINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 66
TABLE 64 AQUACULTURE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 67
TABLE 65 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 69
TABLE 66 LIVE ATTENUATED VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 70
TABLE 67 NORTH AMERICA: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 70
TABLE 68 ASIA PACIFIC: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 71
TABLE 69 INACTIVATED VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 71
TABLE 70 NORTH AMERICA: INACTIVATED VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 72
TABLE 71 ASIA PACIFIC: INACTIVATED VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 72
TABLE 72 TOXOID VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 73
TABLE 73 NORTH AMERICA: TOXOID VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 73
TABLE 74 ASIA PACIFIC: TOXOID VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 73
TABLE 75 RECOMBINANT VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 74
TABLE 76 NORTH AMERICA: RECOMBINANT VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 74
TABLE 77 ASIA PACIFIC: RECOMBINANT VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 75
TABLE 78 OTHER VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 75
TABLE 79 NORTH AMERICA: OTHER VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 76
TABLE 80 ASIA PACIFIC: OTHER VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 76
TABLE 81 VETERINARY VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 78
TABLE 82 EUROPE: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 81
TABLE 83 EUROPE: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 81
TABLE 84 EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 81
TABLE 85 EUROPE: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 82
TABLE 86 EUROPE: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 82
TABLE 87 EUROPE: BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 83
TABLE 88 EUROPE: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 83
TABLE 89 NORTH AMERICA: VETERINARY VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 84
TABLE 90 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 84
TABLE 91 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 85
TABLE 92 NORTH AMERICA: PORCINE VACCINES MARKET, BY DISEASE,
2015–2022 (USD MILLION) 85
TABLE 93 NORTH AMERICA: POULTRY VACCINES MARKET, BY DISEASE,
2015–2022 (USD MILLION) 85
TABLE 94 NORTH AMERICA: BOVINE VACCINES MARKET, BY DISEASE,
2015–2022 (USD MILLION) 86
TABLE 95 NORTH AMERICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 86
TABLE 96 NORTH AMERICA: VETERINARY VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 87
TABLE 97 US: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 88
TABLE 98 US: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 88
TABLE 99 US: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 88
TABLE 100 US: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 89
TABLE 101 US: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 89
TABLE 102 US: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 90
TABLE 103 CANADA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 90
TABLE 104 CANADA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 91
TABLE 105 CANADA: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 91
TABLE 106 CANADA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 91
TABLE 107 CANADA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 92
TABLE 108 CANADA: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 92
TABLE 109 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 95
TABLE 110 ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 95
TABLE 111 ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 95
TABLE 112 ASIA PACIFIC: PORCINE VACCINES MARKET, BY DISEASE,
2015–2022 (USD MILLION) 96
TABLE 113 ASIA PACIFIC: POULTRY VACCINES MARKET, BY DISEASE,
2015–2022 (USD MILLION) 96
TABLE 114 ASIA PACIFIC: BOVINE VACCINES MARKET, BY DISEASE,
2015–2022 (USD MILLION) 97
TABLE 115 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 97
TABLE 116 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 98
TABLE 117 CHINA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 98
TABLE 118 CHINA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 99
TABLE 119 CHINA: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 99
TABLE 120 CHINA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 99
TABLE 121 CHINA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 100
TABLE 122 CHINA: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 100
TABLE 123 THAILAND: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 101
TABLE 124 THAILAND: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 101
TABLE 125 THAILAND: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 102
TABLE 126 THAILAND: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 102
TABLE 127 THAILAND: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 103
TABLE 128 THAILAND: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 103
TABLE 129 INDIA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 104
TABLE 130 INDIA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 104
TABLE 131 INDIA: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 104
TABLE 132 INDIA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 105
TABLE 133 INDIA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 105
TABLE 134 INDIA: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 106
TABLE 135 ROAPAC: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 106
TABLE 136 ROAPAC: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 107
TABLE 137 ROAPAC: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 107
TABLE 138 ROAPAC: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 107
TABLE 139 ROAPAC: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 108
TABLE 140 ROAPAC: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 108
TABLE 141 ROW: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 109
TABLE 142 ROW: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 109
TABLE 143 ROW: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 110
TABLE 144 ROW: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 110
TABLE 145 ROW: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 110
TABLE 146 ROW: BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 111
TABLE 147 ROW: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 111
TABLE 148 RANK OF COMPANIES IN THE VETERINARY VACCINES MARKET, 2017 112


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN: VETERINARY VACCINES MARKET 17
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 19
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 21
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 21
FIGURE 5 DATA TRIANGULATION METHODOLOGY 22
FIGURE 6 VETERINARY VACCINES MARKET, BY TYPE, 2017 VS. 2022 24
FIGURE 7 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017 VS. 2022 25
FIGURE 8 PORCINE VACCINES MARKET, BY DISEASE, 2017 VS. 2022 25
FIGURE 9 VETERINARY VACCINES MARKET, BY REGION 26
FIGURE 10 GROWTH IN LIVESTOCK POPULATION AND REPEATED BREAKOUTS OF LIVESTOCK DISEASES ARE DRIVING THE VETERINARY VACCINES MARKET 27
FIGURE 11 LIVE ATTENUATED VACCINES SEGMENT IS ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2017 28
FIGURE 12 INFECTIOUS BRONCHITIS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017 AND 2022 29
FIGURE 13 APAC IS EXPECTED TO HAVE THE FASTEST CAGR DURING THE FORECAST PERIOD 29
FIGURE 14 VETERINARY VACCINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 30
FIGURE 15 PORCINE VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2017 38
FIGURE 16 LIVE ATTENUATED VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2022 69
FIGURE 17 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 78
FIGURE 18 EUROPE: VETERINARY VACCINES MARKET SNAPSHOT 80
FIGURE 19 ASIA PACIFIC: VETERINARY VACCINES MARKET SNAPSHOT 94
FIGURE 20 ZOETIS: COMPANY SNAPSHOT (2016) 113
FIGURE 21 MERCK & CO. INC.: COMPANY SNAPSHOT (2016) 116
FIGURE 22 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2016) 119
FIGURE 23 ELANCO: COMPANY SNAPSHOT (2016) 122
FIGURE 24 CEVA: COMPANY SNAPSHOT (2016) 125
FIGURE 25 VIRBAC: COMPANY SNAPSHOT (2016) 128


【レポートのキーワード】

動物用ワクチン、種類、疾患、豚、家禽、コンパニオン・アニマル、ペット、水産養殖、動物治療、動物医療

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 動物用ワクチンの世界市場予測(~2022年):種類、疾患、技術別分析(Veterinary/Animal Vaccines Market by Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2022)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆